Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation

Journal of Controlled Release

Volumn 176, Issue 1, 2014, Pages 76-85

  Lu, Ying ^a   Wang, Zhao Hui ^a   Li, Tonglei ^a   McNally, Helen ^b   Park, Kinam ^a,c   Sturek, Michael ^d  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Antitumor fficacy; Keywords; Nanocrystal; Paclitaxel; Taxol; Transferrin

Indexed keywords

ALBUMIN; ANTI-TUMORS; KEYWORDS; PACLITAXEL; TAXOL; TRANSFERRIN;

ANTHROPOMETRY; BODY FLUIDS; DRUG DELIVERY; ENZYME INHIBITION; MAMMALS; PRECIPITATION (CHEMICAL); PROTEINS; TOXICITY; TUMORS;

NANOCRYSTALS;

ALBUMIN; IMMUNOGLOBULIN G; NANOCRYSTAL; PACLITAXEL; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER SIZE; CELL STRAIN KB; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MISCIBILITY; MOUSE; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SUSPENSION; ULTRASOUND;

ALBUMIN; ANTITUMOR EFFICACY; NANOCRYSTAL; PACLITAXEL; TAXOL; TRANSFERRIN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG STABILITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; SERUM ALBUMIN; TAXOIDS; TRANSFERRIN; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84892595073     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.12.018     Document Type: Article

References (56)

1. E. Miele, G.P. Spinelli, F. Tomao, and S. Tomao Albumin-bound formulation of paclitaxel (Abraxane (R) ABI-007) in the treatment of breast cancer Int. J. Nanomedicine 4 2009 99 105
2. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc. Natl. Acad. Sci. U.S.A.-Biol. Sci. 77 1980 1561 1565
3. E.K. Rowinsky, L.A. Cazenave, and R.C. Donehower Taxol - a novel investigational antimicrotubule agent J. Natl. Cancer Inst. 82 1990 1247 1259
4. P.B. Schiff, J. Fant, and S.B. Horwitz Promotion of microtubule assembly in vitro by Taxol Nature 277 1979 665 667
5. K. Yoncheva, P. Calleja, M. Agueros, P. Petrov, I. Miladinova, C. Tsvetanov, and J.M. Irache Stabilized micelles as delivery vehicles for paclitaxel Int. J. Pharm. 436 2012 258 264
6. G. Deepa, N. Ashwanikumar, J.J. Pillai, and G.S.V. Kumar Polymer nanoparticles - a novel strategy for administration of paclitaxel in cancer chemotherapy Curr. Med. Chem. 19 2012 6207 6213
7. S. Sartori, A. Caporale, A. Rechichi, D. Cufari, C. Cristallini, N. Barbani, P. Giusti, and G. Ciardelli Biodegradable paclitaxel-loaded microparticles prepared from novel block copolymers: influence of polymer composition on drug encapsulation and release J. Pept. Sci. 19 2013 205 213
8. H.M. He, S. Chen, J.Z. Zhou, Y. Dou, L. Song, L. Che, X. Zhou, X. Chen, Y. Jia, J.X. Zhang, S.H. Li, and X.H. Li Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel Biomaterials 34 2013 5344 5358
9. H.B. Wang, G. Cheng, Y. Du, L. Ye, W.Z. Chen, L.M. Zhang, T.W. Wang, J.W. Tian, and F.H. Fu Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation Mol. Med. Rep. 7 2013 947 952
10. X.J. Xia, R.F. Guo, Y.L. Liu, P.X. Zhang, C.P. Zhou, D.J. Jin, and R.Y. Wang Formulation characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex Chem. Pharm. Bull. 59 2011 321 326
11. P.P. Lv, W. Wei, H. Yue, T.Y. Yang, L.Y. Wang, and G.H. Ma Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration Biomacromolecules 12 2011 4230 4239
12. E.K. Rowinsky Drug therapy - paclitaxel (Taxol) N. Engl. J. Med. 333 1995 75
13. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598
14. R.B. Weiss, R.C. Donehower, P.H. Wiernik, T. Ohnuma, R.J. Gralla, D.L. Trump, J.R. Baker, D.A. Vanecho, D.D. Vonhoff, and B. Leylandjones Hypersensitivity reactions from Taxol J. Clin. Oncol. 8 1990 1263 1268
15. L. Gianni, C.M. Kearns, A. Giani, G. Capri, L. Vigano, A. Locatelli, G. Bonadonna, and M.J. Egorin Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans J. Clin. Oncol. 13 1995 180 190
16. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840
17. L. Gao, D.R. Zhang, and M.H. Chen Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system J. Nanoparticle Res. 10 2008 845 862
18. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
19. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19
20. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120
21. K. Peters, S. Leitzke, J.E. Diederichs, K. Borner, H. Hahn, R.H. Muller, and S. Ehlers Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection J. Antimicrob. Chemother. 45 2000 77 83
22. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara, and K. Masuda Microemulsion formulation for enhanced absorption of poorly soluble drugs: I Prescription design J. Control. Release 81 2002 65 74
23. G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int. J. Pharm. 125 1995 91 97
24. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems Eur. J. Pharm. Sci. 11 Supplement 2 2000 S93 S98
25. C.M. Keck, and R.H. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16
26. D. Horn, and J. Rieger Organic nanoparticles in the aqueous phase - theory experiment, and use Angew. Chem. Int. Ed. 40 2001 4330 4361
27. J. Junghanns, and R.H. Muller Nanocrystal technology, drug delivery and clinical applications Int. J. Nanomedicine 3 2008 295 309
28. T.Y. Jiang, N. Han, B.W. Zhao, Y.L. Xie, and S.L. Wang Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation Drug Dev. Ind. Pharm. 38 2012 1230 1239
29. D.J. McClements Protein-stabilized emulsions Curr. Opin. Colloid Interface Sci. 9 2004 305 313
30. Y.L. Jeyachandran, E. Mielezarski, B. Rai, and J.A. Mielczarski Quantitative and qualitative evaluation of adsorption/desorption of bovine serum albumin on hydrophilic and hydrophobic surfaces Langmuir 25 2009 11614 11620
31. J.H. Seo, U. Dembereldorj, J. Park, M. Kim, S. Kim, and S.W. Joo Facile internalization of paclitaxel on titania nanoparticles in human lung carcinoma cells after adsorption of serum proteins J. Nanoparticle Res. 14 2012
32. F. Kratz, and B. Elsadek Clinical impact of serum proteins on drug delivery J. Control. Release 161 2012 429 445
33. J.Y. Zhang, B. He, W. Qu, Z. Cui, Y.B. Wang, H. Zhang, J.C. Wang, and Q. Zhang Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo J. Microencapsul. 28 2011 528 536
34. C.J. Vanoss On the mechanism of the cold ethanol precipitation method of plasma-protein fractionation J. Protein Chem. 8 1989 661 668
35. I. Salasoo Distribution of rabbit serum proteins in fractionation by cold ethanol method Anal. Biochem. 20 1967 200
36. L. Smet, P. Colin, W. Ceelen, M. Bracke, J. Bocxlaer, J. Remon, and C. Vervaet Development of a nanocrystalline paclitaxel formulation for hipec treatment Pharm. Res. 29 2012 2398 2406
37. B. Sinha, R.H. Müller, and J.P. Möschwitzer Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size Int. J. Pharm. 453 2013 126 141
38. H.X. Zhang, J.X. Wang, Z.B. Zhang, Y. Le, Z.G. Shen, and J.F. Chen Micronization of atorvastatin calcium by antisolvent precipitation process Int. J. Pharm. 374 2009 106 113
39. Z. Wang, J.F. Chen, Y. Le, Z.G. Shen, and J. Yun Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation Ind. Eng. Chem. Res. 46 2007 4839 4845
40. J.Y. Zhang, Z.G. Shen, J. Zhong, T.T. Hu, J.F. Chen, Z.Q. Ma, and J. Yun Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants Int. J. Pharm. 323 2006 153 160
41. S.V. Dalvi, and R.N. Dave Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation Ind. Eng. Chem. Res. 48 2009 7581 7593
42. H. Zhao, J.X. Wang, Q.A. Wang, J.F. Chen, and J. Yun Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor Ind. Eng. Chem. Res. 46 2007 8229 8235
43. Z.B. Zhang, Z.G. Shen, J.X. Wang, H. Zhao, J.F. Chen, and J. Yun Nanonization of megestrol acetate by liquid precipitation Ind. Eng. Chem. Res. 48 2009 8493 8499
44. H. Zhao, J.X. Wang, H.X. Zhang, Z.G. Shen, J. Yun, and J.F. Chen Facile preparation of danazol nanoparticles by high-gravity anti-solvent precipitation (HGAP) method Chin. J. Chem. Eng. 17 2009 318 323
45. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
46. A.K. Aggarwal, and S. Singh Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000 Drug Dev. Ind. Pharm. 37 2011 1181 1191
47. C. Yang, X. Xu, J. Wang, and Z. An Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions Chem. Pharm. Bull. 60 2012 837 845
48. H. Zhang, C.P. Hollis, Q. Zhang, and T. Li Preparation and antitumor study of camptothecin nanocrystals Int. J. Pharm. 415 2011 293 300
49. X. Jiang, S. Weise, M. Hafner, C. Röcker, F. Zhang, W.J. Parak, and G.U. Nienhaus Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding J. R. Soc. Interface 7 2010 S5 S13
50. T. Serno, J.F. Carpenter, T.W. Randolph, and G. Winter Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-β- cyclodextrin J. Pharm. Sci. 99 2010 1193 1206
51. J.C. Butcher, S. Garg, D. Kim, and P. Sharma A modified approach to predict dissolution and absorption of polydisperse powders Pharm. Res. 25 2008 2309 2311
52. M. Yang, J. Chen, W. Cao, L. Ding, K.K. Ng, H. Jin, Z. Zhang, and G. Zheng Attenuation of nontargeted cell-kill using a high-density lipoprotein-mimicking peptide-phospholipid nanoscaffold Nanomedicine 6 2011 631 641
53. J. Nakamura, N. Nakajima, K. Matsumura, and S. Hyon In vivo cancer targeting of water-soluble Taxol by folic acid immobilization J. Nanomedicine Nanotechnol. 2 2011 106 109
54. Z. Wang, Y. Yu, W. Dai, J. Lu, J. Cui, H. Wu, L. Yuan, H. Zhang, X. Wang, J. Wang, X. Zhang, and Q. Zhang The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer Biomaterials 33 2012 8451 8460
55. C.P. Hollis, H.L. Weiss, M. Leggas, B.M. Evers, R.A. Gemeinhart, and T. Li Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery J. Control. Release 172 2013 12 21
56. Y. Barenholz Doxil® - the first FDA-approved nano-drug: Lessons learned J. Control. Release 160 2012 117 134